These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 9252684)

  • 21. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
    Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
    Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line.
    Shu Y; Liu H
    Biochem Cell Biol; 2007 Oct; 85(5):638-46. PubMed ID: 17901905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levistolide A overcomes P-glycoprotein-mediated drug resistance in human breast carcinoma cells.
    Chen F; Wang T; Wang J; Wang ZQ; Qian M
    Acta Pharmacol Sin; 2008 Apr; 29(4):458-64. PubMed ID: 18358092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chinese herbs of Shenghe Powder reverse multidrug resistance of gastric carcinoma SGC-7901.
    Wang J; Xia Y; Wang H; Hou Z
    Integr Cancer Ther; 2007 Dec; 6(4):400-4. PubMed ID: 18048888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mechanism for P-glycoprotein-mediated apoptosis as revealed by verapamil hypersensitivity.
    Karwatsky J; Lincoln MC; Georges E
    Biochemistry; 2003 Oct; 42(42):12163-73. PubMed ID: 14567677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug resistance phenotype evaluation by immunofluorescence and functional tests: comparison of two monoclonal antibodies and three fluorescent dyes in three cells lines.
    Maynadie M; Lizard G; Solary E; Roignot P; Carli PM
    Anticancer Res; 1994; 14(6B):2605-9. PubMed ID: 7872688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multidrug resistance of leukemia cells to cytostatics--the functional fluorescent dye efflux assay evaluated by flow cytometry].
    Jankovicová K; Krejsek J; Kopecký O
    Vnitr Lek; 2001 Jan; 47(1):25-9. PubMed ID: 15635865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of multidrug resistant phenotype by flow cytometry with monoclonal antibodies and functional tests.
    Lizard G; Maynadié M; Roignot P; Lizard-Nacol S; Poupon MF
    Bull Cancer; 1995 Mar; 82(3):211-7. PubMed ID: 7655150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative flow cytometric determination of anthracycline content of rat bone marrow cells.
    Nooter K; van den Engh G; Sonneveld P
    Cancer Res; 1983 Nov; 43(11):5126-30. PubMed ID: 6616450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric monitoring of fluorescent drug retention and efflux.
    Krishan A; Hamelik RM
    Methods Mol Med; 2005; 111():149-66. PubMed ID: 15911978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Electron microscopy in the differential diagnosis of leukemias and lymphosarcomas].
    Gogichadze GK
    Vopr Onkol; 1980; 26(5):44-9. PubMed ID: 6892971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of multidrug resistance and cell kinetics in a child with near-haploid acute lymphoblastic leukemia.
    Redner A; Hegewisch S; Haimi J; Steinherz P; Jhanwar S; Andreeff M
    Leuk Res; 1990; 14(9):771-7. PubMed ID: 2232849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional multidrug resistance in acute myeloblastic leukaemia: a standardized flow cytometric assay for intracellular daunorubicin accumulation.
    Pallis M; Russell NH
    Br J Haematol; 1998 Jan; 100(1):194-7. PubMed ID: 9450811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression of multidrug resistance (MDR) molecule in acute leukemia and lymphoma.
    Pituch-Noworolska A; Gawlicka M; Balwierz W
    Pol J Pathol; 1995; 46(2):77-82. PubMed ID: 7640950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
    Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
    Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P-glycoprotein mediated multidrug resistance assessment by flow-cytometry in malignant hemopathies.
    Tatu CA; Paunescu V; Stanescu DI; Schneider F
    Anticancer Res; 1997; 17(4A):2583-6. PubMed ID: 9252684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dyes providing increased sensitivity in flow-cytometric dye-efflux assays for multidrug resistance.
    Frey T; Yue S; Haugland RP
    Cytometry; 1995 Jul; 20(3):218-27. PubMed ID: 7587707
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.